SAMANEH FANAEIAN: Open Payments
NPI 1417621434 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 11 payments from 6 companies in 2025. Trend: 2023 $176 · 2024 $317 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $121 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Noven Therapeutics, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Neos Therapeutics, LP | 1 | $21 |
Products named: VRAYLAR, Auvelity, CAPLYTA, Xelstrym, REXULTI, Cotempla XR-ODT.
Industry payments across CA — which companies pay providers there.
